Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Cao

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 2, 2024
Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and designAndrea Teira Calderón, Mauro Chiarito, Ignacio Amat Santos, et al.
Journal of the American Heart Association|August 9, 2024
Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-AnalysisAngelo Oliva, Anna Maria Ioppolo, Mauro Chiarito, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 24, 2023
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney diseaseHuazhen Chen, Alessandro Spirito, Samantha Sartori, et al.
Frontiers in Pharmacology|April 6, 2026
Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of managementSimone Nardin, Francesca Vezzoli, Gianluca Cognolato, et al.
European Heart Journal|March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleedingDavide Cao, Nicolas Amabile, Mauro Chiarito, et al.
The American Journal of Cardiology|December 9, 2022
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary InterventionAlessandro Spirito, Ashutosh Sharma, Davide Cao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 12, 2022
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysisVictor Razuk, Mauro Chiarito, Davide Cao, et al.
Arquivos Brasileiros De Cardiologia|May 8, 2024
Beyond the GRACE ACS Score: Do We Need a Different Model for Men and Women after STEMI?José Sergio Nascimento Silva, Isly Maria Lucena de Barros, Jorge Augusto Nunes Guimarães, et al.
Acta Diabetologica|November 4, 2025
GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromesMauro Gitto, Federica Catapano, Marco Francone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 23, 2022
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysisJohny Nicolas, George Dangas, Mauro Chiarito, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 2, 2024
Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and designAndrea Teira Calderón, Mauro Chiarito, Ignacio Amat Santos, et al.
Journal of the American Heart Association|August 9, 2024
Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-AnalysisAngelo Oliva, Anna Maria Ioppolo, Mauro Chiarito, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 24, 2023
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney diseaseHuazhen Chen, Alessandro Spirito, Samantha Sartori, et al.
Frontiers in Pharmacology|April 6, 2026
Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of managementSimone Nardin, Francesca Vezzoli, Gianluca Cognolato, et al.
European Heart Journal|March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleedingDavide Cao, Nicolas Amabile, Mauro Chiarito, et al.
The American Journal of Cardiology|December 9, 2022
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary InterventionAlessandro Spirito, Ashutosh Sharma, Davide Cao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 12, 2022
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysisVictor Razuk, Mauro Chiarito, Davide Cao, et al.
Arquivos Brasileiros De Cardiologia|May 8, 2024
Beyond the GRACE ACS Score: Do We Need a Different Model for Men and Women after STEMI?José Sergio Nascimento Silva, Isly Maria Lucena de Barros, Jorge Augusto Nunes Guimarães, et al.
Acta Diabetologica|November 4, 2025
GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromesMauro Gitto, Federica Catapano, Marco Francone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 23, 2022
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysisJohny Nicolas, George Dangas, Mauro Chiarito, et al.
Pageof 15